Related Experiment Video
Updated: May 22, 2026

05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Eosinophilic dermatosis of hematologic malignancy.
Michele J Farber1, Sal La Forgia, Joya Sahu
1Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Journal of Cutaneous Pathology
|May 23, 2012
Summary
Eosinophilic dermatosis, an eosinophil-rich skin condition, can manifest with hematologic malignancies like chronic lymphocytic leukemia (CLL). This rare dermatitis mimics insect bites but is linked to underlying blood cancers.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Eosinophilic dermatosis is a rare skin condition characterized by an eosinophil-rich infiltrate.
- It is associated with various hematologic malignancies, most commonly chronic lymphocytic leukemia (CLL).
- The condition presents clinically and histopathologically similar to insect bites, though patients often report no history of bites.
Observation:
- This report details a case of eosinophilic dermatosis in a patient with a known history of CLL.
- The patient presented with a pruritic, papular, and vesicular eruption.
- Histopathological examination revealed an eosinophil-rich infiltrate.
Findings:
- The case highlights the association between eosinophilic dermatosis and chronic lymphocytic leukemia (CLL).
- This presentation underscores the importance of considering underlying hematologic malignancies in eosinophilic dermatosis.
- The findings align with previous descriptions of this rare dermatitis.
Implications:
- Recognizing eosinophilic dermatosis as a potential sign of hematologic malignancy is crucial for timely diagnosis and treatment.
- Further research into the pathogenesis of eosinophilic dermatosis in the context of CLL may improve patient outcomes.
- This case contributes to the understanding of cutaneous manifestations of hematologic cancers.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
